Investing.com - Ipsen reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Ipsen announced earnings per share of €6.52 on revenue of €690.1M. Analysts polled by Investing.com anticipated EPS of €3.80 on revenue of €704.52M.
Ipsen shares are up 1% from the beginning of the year, still down 21.22% from its 52 week high of €95.90 set on September 17, 2020. They are broadly in line with the TR UK 50 which is up 1.04% from the start of the year.
Ipsen follows other major Healthcare sector earnings this month
Ipsen's report follows an earnings beat by Sanofi on February 5, who reported EPS of €1.22 on revenue of €9.38B, compared to forecasts EPS of €1.15 on revenue of €9.54B.
Sartorius Stedim had matched expectations on January 27 with fourth quarter EPS of €1.14 on revenue of €530.6M, compared to forecast for EPS of €1.14 on revenue of €530.6M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar